Centro Paulista de Investigacao Clinica - CEPIC

São Paulo, São Paulo 04266-010

1 studies enrolling now · 2 studies all time

What they study most

Moderately to Severely Active Ulcerative Colitis, Rheumatoid Arthritis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis — Completed